• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖耐量受损进展为非胰岛素依赖型糖尿病的速率及预测因素的新数据。

New data on the rate of progression of impaired glucose tolerance to NIDDM and predicting factors.

作者信息

Heine R J, Nijpels G, Mooy J M

机构信息

Institute for Research in Extramural Medicine, Vrije Universiteit, Amsterdam, The Netherlands.

出版信息

Diabet Med. 1996;13(3 Suppl 2):S12-4.

PMID:8689855
Abstract

The Hoorn study has investigated the prevalence of impaired glucose tolerance (IGT) and diabetes in a random sample of the population, 50-75 years of age, in the small Dutch town of Hoorn. The percentage of the population identified as having IGT was 10.3%, while 8.4% had diabetes. The prevalence of both diabetes and IGT was higher in older subjects (70-74 years of age) than in younger subjects (50-54 years of age), suggesting that age is a major determinant of the prevalence of IGT and diabetes in a population. A prospective study of the development of non-insulin dependent diabetes mellitus (NIDDM) in the subjects identified as having IGT was then initiated. Preliminary results for the 158 subjects who have been followed for a mean of 2 years indicated that 28.5% (95% confidence interval, 15-42%) have progressed to NIDDM within this period. The progression rate calculated from this value is 13.8%/year (95% confidence interval, 3.5-24%/year). Analysis of possible determinants of conversion has revealed that 2-hour plasma glucose levels greater than 9.4 mmol/litre and increased fasting proinsulin levels are predictive of progression to NIDDM. This suggests that beta cell dysfunction, rather than increased insulin resistance, is responsible for the development of NIDDM.

摘要

霍伦研究调查了荷兰小镇霍伦50至75岁随机抽样人群中糖耐量受损(IGT)和糖尿病的患病率。被确定患有IGT的人群比例为10.3%,而患有糖尿病的比例为8.4%。糖尿病和IGT的患病率在老年受试者(70至74岁)中高于年轻受试者(50至54岁),这表明年龄是人群中IGT和糖尿病患病率的主要决定因素。随后对被确定患有IGT的受试者进行了非胰岛素依赖型糖尿病(NIDDM)发展的前瞻性研究。对平均随访2年的158名受试者的初步结果表明,在此期间28.5%(95%置信区间,15 - 42%)已进展为NIDDM。根据该值计算的进展率为13.8%/年(95%置信区间,3.5 - 24%/年)。对可能的转变决定因素的分析表明,2小时血浆葡萄糖水平大于9.4毫摩尔/升和空腹胰岛素原水平升高可预测进展为NIDDM。这表明β细胞功能障碍而非胰岛素抵抗增加是NIDDM发生的原因。

相似文献

1
New data on the rate of progression of impaired glucose tolerance to NIDDM and predicting factors.糖耐量受损进展为非胰岛素依赖型糖尿病的速率及预测因素的新数据。
Diabet Med. 1996;13(3 Suppl 2):S12-4.
2
Impaired glucose tolerance--prevalence and conversion to NIDDM.糖耐量受损——患病率及向非胰岛素依赖型糖尿病的转变
Diabet Med. 1996;13(3 Suppl 2):S9-11.
3
Prevalence and incidence of NIDDM in Daqing City.大庆市非胰岛素依赖型糖尿病的患病率与发病率
Chin Med J (Engl). 1996 Aug;109(8):599-602.
4
The clinical implications of impaired glucose tolerance.糖耐量受损的临床意义。
Diabet Med. 1996 Nov;13(11):927-37. doi: 10.1002/(SICI)1096-9136(199611)13:11<927::AID-DIA279>3.0.CO;2-E.
5
Screening for noninsulin dependent diabetes mellitus and impaired glucose tolerance in a Dunedin general practice--is it worth it?在达尼丁一家普通诊所筛查非胰岛素依赖型糖尿病和糖耐量受损——这值得吗?
N Z Med J. 1992 Jun 10;105(935):208-10.
6
Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.评估向糖耐量受损和2型糖尿病的进展情况。
Eur J Clin Invest. 2006 Nov;36(11):796-802. doi: 10.1111/j.1365-2362.2006.01728.x.
7
High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius.毛里求斯2型糖尿病发病率高,空腹血糖受损和糖耐量受损向糖尿病的转化率不断上升。
J Intern Med. 2004 Jul;256(1):37-47. doi: 10.1111/j.1365-2796.2004.01336.x.
8
Impaired glucose metabolism in colorectal cancer.结直肠癌中的葡萄糖代谢受损。
Scand J Gastroenterol. 2006 Sep;41(9):1079-86. doi: 10.1080/00365520600587444.
9
Prevalence of abnormal glucose tolerance in Khon Kaen Province and validity of urine stick and fasting blood sugar as screening tools.孔敬府异常糖耐量的患病率以及尿糖试纸和空腹血糖作为筛查工具的有效性。
J Med Assoc Thai. 1997 Jun;80(6):363-71.
10
Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.胰高血糖素反应对糖耐量受损男性和2型糖尿病患者餐后高血糖的影响。
Metabolism. 2005 Sep;54(9):1168-73. doi: 10.1016/j.metabol.2005.03.024.

引用本文的文献

1
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.血糖中度升高人群中2型糖尿病的发生
Cochrane Database Syst Rev. 2018 Oct 29;10(10):CD012661. doi: 10.1002/14651858.CD012661.pub2.
2
Postmarketing surveillance of acarbose treatment in Taiwanese patients with type 2 diabetes mellitus.台湾2型糖尿病患者使用阿卡波糖治疗的上市后监测
Clin Drug Investig. 2006;26(10):559-65. doi: 10.2165/00044011-200626100-00002.
3
Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data.
阿卡波糖用于预防糖耐量受损受试者的2型糖尿病、高血压和心血管疾病:关于对STOP-NIDDM试验数据批判性分析的事实与解读
Diabetologia. 2004 Jun;47(6):969-75; discussion 976-7. doi: 10.1007/s00125-004-1409-4. Epub 2004 May 26.
4
Rates and risks for co-morbid depression in patients with Type 2 diabetes mellitus: results from a community-based study.2型糖尿病患者共病抑郁症的发生率及风险:一项基于社区研究的结果
Diabetologia. 2003 Jul;46(7):892-8. doi: 10.1007/s00125-003-1124-6. Epub 2003 Jun 18.
5
Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion.从糖耐量受损进展为2型糖尿病:早期胰岛素分泌受损的核心作用。
Curr Diab Rep. 2002 Jun;2(3):242-8. doi: 10.1007/s11892-002-0090-6.